Cross-fund · 5 holders
IKT
INHIBIKASE THERAPEUTICS INC
CUSIP 45719W205
5
Tracked holders
$26.8M
Aggregate value
14,933,082
Shares
5
Active funds
Funds holding IKT
| Fund | Strategy | Period | Value | % of book | Δ shares | Status |
|---|---|---|---|---|---|---|
| BlackRock | Institutional | Q1 2026 | $10.6M | — | +2,997,859 | +90.7% |
| Vanguard | Institutional | Q4 2025 | $9.3M | — | +1,285,265 | +39.3% |
| Millennium | Multi-Strategy | Q1 2026 | $4.9M | — | +2,758,227 | +1623.9% |
| Citadel | Multi-Strategy | Q1 2026 | $1.9M | — | −141,045 | −11.3% |
| Point72FEAT | Multi-Strategy | Q1 2026 | $67,843 | — | +40,383 | NEW |
Aggregated from the latest 13F-HR per tracked fund (longs only). QoQ deltas compare against each fund's prior quarterly filing.